Last10K.com

Oncosec Medical Inc (ONCS) SEC Filing 8-K Material Event for the period ending Tuesday, January 9, 2018

Oncosec Medical Inc

HISTORY TOOLS
CIK: 1002638 Ticker: ONCS

View differences made from one to another to evaluate Oncosec Medical Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Oncosec Medical Inc.

Continue

Assess how Oncosec Medical Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Oncosec Medical Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools

Material Contracts, Statements, Certifications & more

Oncosec Medical Inc provided additional information to their SEC Filing as exhibits

Exhibit 10.1: Material Contract
Ticker: ONCS
CIK: 1444307
Form Type: 8-K Corporate News
Accession Number: 0001493152-18-000522
Submitted to the SEC: Fri Jan 12 2018 5:13:41 PM EST
Accepted by the SEC: Fri Jan 12 2018
Period: Tuesday, January 9, 2018
Industry: Pharmaceutical Preparations
Events:
  1. Event for Officers
  2. Financial Exhibit
  3. Vote of Security Holders

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/oncs/0001493152-18-000522.htm